Cure Available for Hepatitis C but Oregon Limits Access
Sonia Canzater | Leave a Comment
5 years ago, drugs to treat Hepatitis C called direct-acting retrovirals came out into the market. These drugs had cure rates of more than 90% of Hepatitis C infections. However, due to the costs of the drug, the Oregon Health Plan which is the State’s version of Medicaid limits access to only the sickest individuals.
In January of this year, Oregon’s Medicaid loosened its rules and allowed people with less severe damage or those deemed fibrosis stage two through four to have access. However, stage 1 is still currently denied access contrary to guidelines of health professional groups.
For more information, see: https://www.opb.org/news/article/oregon-hepatitis-c-cure-opioid-epidemic/